Israel Englander Innate Pharma Sa Call Options Transaction History
Millennium Management LLC
- $224 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding IPHA
# of Institutions
10Shares Held
254KCall Options Held
0Put Options Held
0-
Exchange Traded Concepts, LLC113KShares$232,9240.01% of portfolio
-
Optiver Holding B.V. Amsterdam, P770.6KShares$145,3610.01% of portfolio
-
Morgan Stanley New York, NY44.1KShares$90,8950.0% of portfolio
-
Jane Street Group, LLC New York, NY14.6KShares$29,9810.0% of portfolio
-
Barclays PLC London, X0412Shares$8480.0% of portfolio
About Innate Pharma SA
- Ticker IPHA
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 79,893,000
- Market Cap $165M
- Description
- Innate Pharma S.A., a biotechnology company, discovers, develops, and commercializes therapeutic antibodies for the treatment of oncology indications in France and internationally. The company's products include Lacutamab (IPH4102), an anti-KIR3DL2 antibody, which is in Phase II clinical trials for the treatment of cutaneous T-cell and periphera...